Floatz logo

gsk1120212

Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent

Princess Maxima Center for Pediatric OncologyPhase 1/2Active
CC
45/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
81/ 100

Competitive context

48 Active assets in the Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent cohort.

Asset / SponsorPhaseRating
PREDNISONE TABLETS
Children's Oncology Group
Phase 3BB
Cyclophosphamide
Children's Oncology Group
Phase 3BB
Cytosin-Arabinosid
Princess Maxima Center for Pediatric Oncology
Phase 3BB
ETOPOSIDE
Children's Cancer Group, China
Phase 3BB
Daunorubicin
Children's Oncology Group
Phase 3B

View all 50 →

Same molecule, other indications

gsk1120212 is also rated in:

anaplastic pleomorphic xanthoastrocytomaDormant
BB
Indicative ·
69 / 100
View asset →
Glioma, High GradeDormant
BB
Indicative ·
69 / 100
View asset →
anaplastic oligodendrogliomaDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →